Naho Yakuwa, BPharm, is affiliated with the Japan Drug Information Institute in Pregnancy at the National Center for Child Health and Development and with Social Pharmacy and Regulatory Science at Showa Pharmaceutical University in Tokyo, Japan. Yakuwa has published research focusing on drug safety during pregnancy, specifically addressing the reliability of safety information on drug exposure and pregnancy outcomes related to second-generation antipsychotics in the first trimester. Collaborations include work with Akimasa Yamatani, Atsuko Murashima, Chiaki Uno, Kunihiko Takahashi, and Mikako Goto.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
